Preventive vaginal and intra-urethral devices in the treatment of female urinary stress incontinence.
A number of vaginal and urethral devices have recently been introduced for the treatment of female urinary stress incontinence. Nine recent studies of these were scrutinized. The median corrected subjective cured/improved rate was 63% for the vaginal and 43% for the urethral devices. The latter group have a high percentage of side-effects with related drop-outs. Urinary tract infection and migration of the device into the bladder are particularly worrying. The vaginal devices currently available compete favourably with other non-surgical forms of therapy for stress incontinence in terms of efficacy and safety.
Vierhout
M E
ME
Department of Gynaecology, Ikazia Hospital, Rotterdam, The Netherlands.
Lose
G
G
D005260:Female; D005548:Foreign-Body Migration / Q000209:etiology; D006801:Humans; D010570:Pessaries / Q000009:adverse effects / Q000592:standards* / Q000600:supply & distribution; D019736:Prostheses and Implants / Q000009:adverse effects / Q000592:standards* / Q000600:supply & distribution; D016896:Treatment Outcome; D014521:Urethra; D014550:Urinary Incontinence, Stress / Q000517:prevention & control*; D014552:Urinary Tract Infections / Q000209:etiology; D014621:Vagina